840 results on '"Leclercq, Isabelle A"'
Search Results
2. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles
3. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
4. A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
5. Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
6. Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease
7. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
8. Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
9. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
10. Automated whole slide image analysis for a translational quantification of liver fibrosis
11. GS-003-YI The role of endothelial cells in the ductular reaction-driven regeneration
12. FRI-224 Intramyocellular lipids are associated with insulin resistance in metabolic dysfunction-associated steatotic liver disease
13. THU-272-YI MASH-associated endothelial dysfunction in mice: is there no effect?
14. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity
15. In-depth Clinical, Hemodynamic, and Volumetric Assessment of the Resection and Partial Liver Transplantation With Delayed Total Hepatectomy-Type Auxiliary Liver Transplantation in Noncirrhotic Setting: Are We Simply Dealing With a Transplant Model of...
16. When the liver is in poor condition, so is the heart - cardiac remodelling in MASH mouse models.
17. Vascular damage and excessive proliferation compromise liver function after extended hepatectomy in mice
18. Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?
19. No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: results of the French prospective multicenter REDIAGEN study
20. Les sons et les bruits racontent ma vie quotidienne
21. New discoveries in bile acids, gut microbiota and host interactions in health and diseases.
22. Hypoxia protects the liver from Small For Size Syndrome: A lesson learned from the associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure in rats
23. Invasive Ductular Reaction Operates Hepatobiliary Junctions upon Hepatocellular Injury in Rodents and Humans
24. Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury
25. Vascular damage and excessive proliferation compromise liver function after extended hepatectomy in mice
26. Importance of the gut microbiota in mice with a ‘humanized’ bile acid pool
27. Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis
28. Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH
29. Associating liver partition and portal vein ligation for staged hepatectomy: establishment of an animal model with insufficient liver remnant
30. Intercomparison and analyses of the climatology of the West African Monsoon in the West African Monsoon Modeling and Evaluation project (WAMME) first model intercomparison experiment
31. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles
32. New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis
33. Alcohol-associated bowel disease: new insights into pathogenesis
34. The silencing of Sox9 impairs ductular reaction expansion while enhancing the differentiation of DR cells into hepatocytes
35. Excessive proliferation after extended hepatectomy compromises liver function in mice
36. Increasing gut microbiota produced secondary bile acids to protect against non-alcoholic steatohepatitis
37. Relevance of the CDE and DDC Mouse Models to Study Ductular Reaction in Chronic Human Liver Diseases
38. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults
39. Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages
40. Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans
41. Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease
42. AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers
43. Adipose tissues as endocrine target organs
44. The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis
45. Experimental models of liver fibrosis
46. Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
47. Development of a mouse model for postresectional liver failure
48. The FXR agonist obeticholic acid does not stimulate liver regeneration in hepatectomized mice
49. Liver Fetuin-A at Initiation of Insulin Resistance
50. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.